METHOD OF PHOTODYNAMIC THERAPY (PDT) FOR BLADDER CANCER

    公开(公告)号:US20220152411A1

    公开(公告)日:2022-05-19

    申请号:US17588978

    申请日:2022-01-31

    Applicant: PHOTOCURE ASA

    Abstract: This invention relates to a method of photodynamic therapy (PDT) for bladder cancer and its use as an adjuvant or neoadjuvant therapy in the treatment of bladder cancer. The invention provides a composition comprising hexyl 5-ALA ester (HAL) or a pharmaceutically acceptable salt thereof for use in a method of photodynamic therapy for bladder cancer, wherein said composition is instilled into the bladder of a patient in need of such treatment and the inside of said bladder is exposed to blue light having a fluence rate of 1.5 to 12.5 mW/cm2.

    Method of photodynamic therapy (PDT) for bladder cancer

    公开(公告)号:US11235168B2

    公开(公告)日:2022-02-01

    申请号:US16063142

    申请日:2016-12-19

    Applicant: PHOTOCURE ASA

    Abstract: This invention relates to a method of photodynamic therapy (PDT) for bladder cancer and its use as an adjuvant or neoadjuvant therapy in the treatment of bladder cancer. The invention provides a composition comprising hexyl 5-ALA ester (HAL) or a pharmaceutically acceptable salt thereof for use in a method of photodynamic therapy for bladder cancer, wherein said composition is instilled into the bladder of a patient in need of such treatment and the inside of said bladder is exposed to blue light having a fluence rate of 1.5 to 12.5 mW/cm2.

    NEOADJUVANT THERAPY FOR BLADDER CANCER
    3.
    发明申请

    公开(公告)号:US20200155683A1

    公开(公告)日:2020-05-21

    申请号:US16748332

    申请日:2020-01-21

    Applicant: PHOTOCURE ASA

    Inventor: Kjetil Hestdal

    Abstract: This invention relates to a neoadjuvant therapy for bladder cancer in bladder cancer patients who are scheduled for a cystectomy and methods of carrying out such a neoadjuvant therapy. In particular, the invention relates to a composition comprising hexyl 5-ALA ester (HAL) or a pharmaceutically acceptable salt thereof for use in a neoadjuvant therapy for bladder cancer in a bladder cancer patient who is scheduled for a cystectomy, the therapy comprises instilling said composition into the bladder of said patient and exposing the inside of said bladder to light.

    Neoadjuvant therapy for bladder cancer

    公开(公告)号:US11311620B2

    公开(公告)日:2022-04-26

    申请号:US16748332

    申请日:2020-01-21

    Applicant: PHOTOCURE ASA

    Inventor: Kjetil Hestdal

    Abstract: This invention relates to a neoadjuvant therapy for bladder cancer in bladder cancer patients who are scheduled for a cystectomy and methods of carrying out such a neoadjuvant therapy. In particular, the invention relates to a composition comprising hexyl 5-ALA ester (HAL) or a pharmaceutically acceptable salt thereof for use in a neoadjuvant therapy for bladder cancer in a bladder cancer patient who is scheduled for a cystectomy, the therapy comprises instilling said composition into the bladder of said patient and exposing the inside of said bladder to light.

    METHOD OF PHOTODYNAMIC THERAPY (PDT) FOR BLADDER CANCER

    公开(公告)号:US20190022404A1

    公开(公告)日:2019-01-24

    申请号:US16063142

    申请日:2016-12-19

    Applicant: PHOTOCURE ASA

    Abstract: This invention relates to a method of photodynamic therapy (PDT) for bladder cancer and its use as an adjuvant or neoadjuvant therapy in the treatment of bladder cancer. The invention provides a composition comprising hexyl 5-ALA ester (HAL) or a pharmaceutically acceptable salt thereof for use in a method of photodynamic therapy for bladder cancer, wherein said composition is instilled into the bladder of a patient in need of such treatment and the inside of said bladder is exposed to blue light having a fluence rate of 1.5 to 12.5 mW/cm2

    Neoadjuvant therapy for bladder cancer

    公开(公告)号:US10556010B2

    公开(公告)日:2020-02-11

    申请号:US16063185

    申请日:2016-12-19

    Applicant: PHOTOCURE ASA

    Inventor: Kjetil Hestdal

    Abstract: This invention relates to a neoadjuvant therapy for bladder cancer in bladder cancer patients who are scheduled for a cystectomy and methods of carrying out such a neoadjuvant therapy. In particular the invention relates to a composition comprising hexyl 5-ALA ester (HAL) or a pharmaceutically acceptable salt thereof for use in a neoadjuvant therapy for bladder cancer in a bladder cancer patient who is scheduled for a cystectomy, the therapy comprises instilling said composition into the bladder of said patient and exposing the inside of said bladder to light.

Patent Agency Ranking